Observation plans in longitudinal studies with time-varying treatments

Statistical Methods in Medical Research

Volumn 18, Issue 1, 2009, Pages 27-52

  Hernán, Miguel A ^a   McAdams, Mara ^b   McGrath, Nuala ^c   Lanoy, Emilie ^d   Costagliola, Dominique ^d  

^a HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; VIRUS RNA;

ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL OBSERVATION; COHORT ANALYSIS; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LONGITUDINAL STUDY; LYMPHOCYTE COUNT; MATHEMATICAL MODEL; OUTCOME ASSESSMENT; PROBABILITY; SYSTEMATIC ERROR; TIME; TREATMENT OUTCOME; WOMEN'S HEALTH;

HUMANS; LONGITUDINAL STUDIES; MODELS, STATISTICAL; OBSERVATION; PHARMACOEPIDEMIOLOGY;

EID: 58849099919     PISSN: 09622802     EISSN: None     Source Type: Journal    
DOI: 10.1177/0962280208092345     Document Type: Article

References (23)

1. Kaslow RA, Ostrow DG, Detels R., Phair JP, Polk BF, Rinaldo CR The Multicenter AIDS Cohort Study: Rationale, organization, and selected characteristics of the participants. American Journal of Epidemiology 1987; 126: 310-18.
2. Grodstein F., Manson JE, Colditz GA, Willett WC, Speizer FE, Stampfer MJ A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Annals of Internal Medicine 2000; 133: 933-41.
3. Grabar SV, Le Moing V., Goujard C., Leport C., Kazatchkine MD, Costagliola D., Weiss L. Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy. Annals of Internal Medicine 2000; 133: 401-10.
4. Robins JM Marginal structural models. 1997 Proceedings of the Section on Bayesian Statistical Science. American Statistical Association, Alexandria, VA, 1998: 1-10.
5. Robins JM Marginal structural models versus structural nested models as tools for causal inference. In: Halloran E, Berry D, eds. Statistical Models in Epidemiology: The Environment and Clinical Trials. Springer-Verlag, New York, 1999: 95-134.
6. Robins JM, Rotnitzky A., Zhao LP Analysis of semiparametric regression models for repeated outcomes in the presence of missing data. Journal of the American Statsitical Association 1995; 90: 106-21.
7. Hernán MA, Brumback B., Robins JM Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures. Statistics in Medicine 2002; 21: 1689-709.
8. Cole SR, Hernán MA, Margolick JB, Cohen MH, Robins JM Marginal structural models to estimate the effect of highly active antiretroviral therapy initiation on CD4 cell count. American Journal of Epidemiology 2005; 162: 471-78.
9. Robins JM, Hernán MA Estimation of the causal effects of time-varying exposures. In: Advances in Longitudinal Data Analysis. Fitzmaurice G, Davidian M, Verbeke G, Molenberghs G, eds. New York, Chapman and Hall/CRC Press; 2008.
10. Robins JM A new approach to causal inference in mortality studies with a sustained exposure period Application to the healthy worker survivor effect [published errata appear in Math Modelling, 14, 917-21 (1987)]. Mathematical Modelling 1986; 7: 1393-512.
11. Hernán MA, Hernández-Díaz S., Robins JM A structural approach to selection bias. Epidemiology 2004; 15: 615-25.
12. Liang KY, Zeger SL Longitudinal data analysis using generalized linear models. Biometrika 1986; 73: 13-22.
13. Zeger SL, Liang KY Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1982; 42: 121-30.
14. Pierce DA The asymptotic effect of substituting estimators for parameters in certain types of statistics. The Annals of Statistics 1982; 10: 475-78.
15. Robins JM, Greenland S. Comment on 'Causal inference without counterfactuals.' Journal of the American Statistical Association 2000; 95: 477-82.
16. Hernán MA, Taubman SL Does obesity shorten life? The importance of well defined interventions to answer causal questions. International journal of obesity 2008 (in press).
17. Cole SR, Hernán MA, Robins JM, Anastos K., Chmiel J., Detels R., Ervin C., Feldman J., Greenblatt R., Kingsley L., Lai S., Young M., Cohen M., Muñoz A. Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models. American Journal of Epidemiology 2003; 158: 687-94.
18. Hernán MA, Brumback B., Robins JM Marginal structural models to estimate the joint effect of non randomized treatments. Journal of the American Statistical Association 2001; 96: 440-48.
19. Hernán MA Confounding. In: Everitt B, Melnick E, eds. Encyclopedia of Quantitative Risk Assessment. New York, John Wiley; 2008 (in press).
20. Patel K., Hernán MA, Williams PL, Seeger JD, McIntosh K., Seage GR, for the Pediatric AIDS Clinical Trials Group 219/219C Study Team. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents infected with HIV-1: A ten year follow-up study. Clinical Infectious Diseases 2008; 46: 507-15.
21. Shepherd BE, Gilbert PB, Jemiai Y., Rotnitzky A. Sensitivity analyses comparing outcomes only existing in a subset selected post-randomization, conditional on covariates, with application to HIV vaccine trials. Biometrics 2006; 62: 332-42.
22. Lin H., Scharfstein DO, Rosenheck RA Analysis of longitudinal data with irregular, outcome-dependent follow-up. Journal of the Royal Statistical Association 2004; 66: 791-813.
23. Orellana L., Rotnitzky A. Estimation of the effect of dynamic treatment regimes under flexible dynamic visit regimes. Technical Report, Department of Biostatistics, Harvard School of Public Health, 2007.